AVX-701

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameAVX-701
Drug Alias NameCarcinoembryonic antigen [CEA(6D)]-expressing virus-like replicon particle (VRP) immunotherapy - AlphaVaxCancer vaccine VRP-CEA - AlphaVaxVRP-CEA vaccine,Carcinoembryonic antigen [CEA(6D)]-expressing virus-like replicon particle (VRP) immunotherapyCEA(6D) VRP vaccineCancer vaccine VRP-CEA +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsCarcinoembryonic antigen stimulants
TargetsCarcinoembryonic antigen
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlphavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuke UniversityAlphavax Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A